Moreover, a recent animal study has suggested that a low dose of Delta24‐RGD oncolytic adenovirus can upregulate PD‐1 expression on CD8+ T cells, leading to a more effective anti‐tumor response.49 This evidence concerns the gene PDCD1 and neoplasm.